netbook
desktop
mobile
tablet-landscape
tablet
phone-landscape
phone
Research to Prevent Blindness

Emerging Vision Scientists Visit Capitol Hill

On September 15, the National Alliance for Eye and Vision Research (NAEVR) held its Advocacy Day, supported by Research to Prevent Blindness (RPB), in which 22 emerging vision scientists conducted 50 Capitol Hill visits to discuss their work and champion the need for continued federal funding for critical vision research.

Emerging vision scientists visit the office of Senator Kirsten Gillibrand

Emerging vision scientists and RPB visit the office of Senator Kirsten Gillibrand 

NAEVR's message that "research does not have a pause button" was well received by congressional staff and the eight members of Congress who met directly with the emerging vision scientists. RPB President Brian Hofland, PhD, accompanied several of the emerging vision scientists on their visits with congressional staff, and stressed the need to fund young researchers through both foundations and non-profits (such as RPB) and federal grants.

The young researchers appreciated the opportunity to speak about their work in a political forum. "Personally, I was quite enlightened by these visits in gaining an understanding of the nuts and bolts of how science policy and funding decisions are made at the government level. I feel that this experience helped me to better develop skills to 'sell research' to non-scientists who play a critical role in funding vision research," said Daniel Chao, MD, PhD, from the University of California San Diego.

Emerging vision scientists at AVER Congressional reception

Emerging vision scientists attend the AVER Congressional reception 

Prior to going to the Hill, on September 14 the emerging vision scientists displayed posters of their research at an evening Congressional reception hosted by the Alliance for Eye and Vision Research (AVER, which is NAEVR's associated non-profit educational organization) at which National Eye Institute Director Paul Sieving, MD, PhD, spoke and members of Congress has a chance to interact with the young researchers.

On September 28, just weeks after Advocacy Day, Congress passed a short-term Continuing Resolution that funds the government through the end of 2016--one of the requests NAEVR, RPB and the emerging vision scientists made at their visits. They also advocated for Congressional representatives to return following the election in November to complete 2017 appropriations, including a $2 billion National Institutes of Health funding increase to $34.1 billion.

 

 

 

Related News: Top Story

In Memoriam: John I. Bloomberg

With deep sorrow, Research to Prevent Blindness (RPB) announces the passing of John I. Bloomberg, who served on the RPB Board of Trustees from 2007 to 2017.

Read More

 

RPB AWARDS $5.4 MILLION IN GRANTS

The latest grant cycle supports eye research related to a variety of diseases and conditions.

Read More

 

Natural Compound Reduces Signs of Aging, Including Eye Dryness

RPB-supported vision researchers at Washington University School of Medicine in St. Louis have contributed key data to a new study that identifies a natural compound that slows typical signs of aging in mice.

Read More

 

Researchers Identify Treatment Target for Blinding Retinal Diseases

A common pathway involved in photoreceptor death has been identified in retinitis pigmentosa, advanced dry age-related macular degeneration and other retinal diseases, with early evidence of a possible halt to vision loss related to pathway treatment.

Read More

 

New Report Aims to Make Eye Health a Public Health Priority

The National Academies of Sciences, Engineering, and Medicine issues nine concrete recommendations for improving eye and vision health and increasing health equity.

Read More

 

Zika Virus Found in Tears

Researchers publish critical findings from Zika mouse model, raising the possibility of new avenues of transmission, as well as confirming the virus’ ability to induce cell death in eyes.

Read More

 

Subscribe

Get our email updates filled with the latest news from our researchers about preventing vision loss, treating eye disease and even restoring sight. Unsubscribe at any time. Under our privacy policy, we'll never share your contact information with a third party.